Capital International LTD Gilead Sciences, Inc. Transaction History

Capital International LTD

  • $2.23 Billion
  • Q3 2024

A detailed history of Capital International LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital International LTD holds 66,551 shares of GILD stock, worth $6.26 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
66,551
Previous 65,380 1.79%
Holding current value
$6.26 Million
Previous $4.49 Million 24.37%
% of portfolio
0.25%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$66.59 - $83.99 $77,976 - $98,352
1,171 Added 1.79%
66,551 $5.58 Million
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $34,037 - $39,282
-539 Reduced 0.82%
65,380 $4.49 Million
Q1 2024

May 14, 2024
BUY
$71.58 - $87.29 $106,153 - $129,451
1,483 Added 2.3%
65,919 $4.83 Million
Q4 2023

Feb 13, 2024
SELL
$73.27 - $83.09 $15,459 - $17,531
-211 Reduced 0.33%
64,436 $5.22 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $1.89 Million - $2.06 Million
25,528 Added 65.26%
64,647 $4.84 Million
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $2.97 Million - $3.39 Million
39,119 New
39,119 $3.01 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $1 Million - $1.09 Million
-15,778 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $243,180 - $277,468
-4,053 Reduced 20.44%
15,778 $1.02 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $554,863 - $697,644
-8,935 Reduced 31.06%
19,831 $1.25 Million
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $1.74 Million - $2.02 Million
-24,000 Reduced 45.48%
28,766 $2.21 Million
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $2.45 Million - $3.14 Million
39,186 Added 288.56%
52,766 $3.95 Million
Q4 2019

Feb 18, 2020
BUY
$61.62 - $67.78 $313,029 - $344,322
5,080 Added 59.76%
13,580 $882,000
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $531,335 - $586,500
8,500 New
8,500 $539,000
Q1 2019

May 15, 2019
SELL
$62.53 - $70.05 $2.28 Million - $2.56 Million
-36,484 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $1.21 Million - $1.58 Million
20,029 Added 121.72%
36,484 $2.28 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $621,918 - $688,577
-8,725 Reduced 34.65%
16,455 $1.27 Million
Q2 2018

Aug 14, 2018
SELL
$64.88 - $75.68 $230,453 - $268,815
-3,552 Reduced 12.36%
25,180 $1.78 Million
Q1 2018

May 15, 2018
BUY
$72.84 - $88.8 $55,722 - $67,932
765 Added 2.74%
28,732 $2.17 Million
Q4 2017

Feb 14, 2018
SELL
$71.15 - $83.52 $6.32 Million - $7.42 Million
-88,790 Reduced 76.05%
27,967 $2 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $8.42 Million - $9.98 Million
116,757
116,757 $9.46 Million

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Capital International LTD Portfolio

Follow Capital International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email